Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cariprazin, ATC N05AX15 für die Zeit 01.10.2025 - 30.09.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Hausstaubmilben (ausschl. Acarizax), ATC V01AA03 für die Zeit 01.10.2025 - 30.09.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tacrolimus, ATC D11AH01 für die Zeit 01.10.2025 - 30.09.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Relugolix, ATC L02BX04 für die Zeit 01.10.2025 - 30.09.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Hausstaubmilben (ausschl. Orylmyte), ATC V01AA03 für die Zeit 01.10.2025 - 30.09.2027
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-08
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
TEN
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-Westfalen
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
TEN
Lithuania – Laboratory services – KELIŲ ĮRENGIMUI NAUDOJAMŲ MEDŽIAGŲ IR GAMINIŲ KONTROLINIŲ LABORATORINIŲ BANDYMŲ PASLAUGOS (ŽENKLINIMAS IR GRINDINYS)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV90
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV90
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV89
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV88
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Wirkstoffen (Arzneimitteln) - VV 86
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Naloxegol -VV 86
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu biosimilaren Wirkstoffen ab dem 01.10.2025
ted.europa.eu
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 10, 2027
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
GRA
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
grants.gov
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative...
GrantCash GrantUnited StatesOpen
AmountAward ceiling: $150,000
DeadlineAug 11, 2027
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
TEN
Spain – Envelopes – Sistema Dinámico de Adquisición para la contratación del suministro de sobres de distintas categorías para la S.E. Correos y Telégrafos, S.A., S.M.E. Tres categorías: - Categoría 1: sobres preimpresos de hasta 1 ventana. - Categoría 2:
ted.europa.eu
Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restric...
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 13, 2027
Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-13
TEN
Slovakia – Cut flowers – Dodanie živých kvetov, umelých kvetov a dekoračného materiálu pre potreby MARIANUM - Pohrebníctvo mesta Bratislavy
ted.europa.eu
Buyer: MARIANUM - Pohrebníctvo mesta Bratislavy | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-15
TenderProcurement ContractSlovakiaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 15, 2027
Buyer: MARIANUM - Pohrebníctvo mesta Bratislavy | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-15
TEN
Lithuania – Architectural design services – VP-722, Architektūrinio projektavimo paslaugos
ted.europa.eu
Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-15
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 15, 2027
Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-15
TEN
Spain – Printing paper – Sistema Dinámico de Adquisición, para la contratación del suministro de papel de distintas categorías para la S.E. Correos y Telégrafos, S.A., S.M.E. Categoría 1: Bobinas de papel blanco. Categoría 2:Papel preimpreso en bobina, pr
ted.europa.eu
Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restric...
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 17, 2027
Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-17
GRA
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
grants.gov
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 18, 2027
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and there...
TEN
Bulgaria – Pharmaceutical products – Доставки на медикаменти
ted.europa.eu
Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р СТАМЕН ИЛИЕВ АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadli...
TenderProcurement ContractBulgariaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 19, 2027
Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р СТАМЕН ИЛИЕВ АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-19
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
34701
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cariprazin, ATC N05AX15 für die Zeit 01.10.2025 - 30.09.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Hausstaubmilben (ausschl. Acarizax), ATC V01AA03 für die Zeit 01.10.2025 - 30.09.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Hausstaubmilben (ausschl. Orylmyte), ATC V01AA03 für die Zeit 01.10.2025 - 30.09.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05
34707
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-WestfalenBuyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Slovakia – Services incidental to logging – DNS - Lesnícke služby v ťažbovom procese na OZ Východ, OZ Šariš, OZ Vihorlat, OZ UličBuyer: LESY Slovenskej republiky, štátny podnik | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline...
Tender
Procurement Contract
Slovakia
Not provided on the source page. Please check the official source.
Buyer: LESY Slovenskej republiky, štátny podnik | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-07
34711
Bulgaria – Pharmaceutical products – „Доставка на онкологични лекарствени продукти за нуждите на УМБАЛ" Света Екатерина“ ЕАДBuyer: Университетска многопрофилна болница за активно лечение "Света Екатерина" ЕАД | Notice type: cn-standard | Procedure: restr...
Tender
Procurement Contract
Bulgaria
Not provided on the source page. Please check the official source.
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
34718
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu biosimilaren Wirkstoffen ab dem 01.10.2025Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10
34719
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or c...
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
34720
Spain – Envelopes – Sistema Dinámico de Adquisición para la contratación del suministro de sobres de distintas categorías para la S.E. Correos y Telégrafos, S.A., S.M.E. Tres categorías: - Categoría 1: sobres preimpresos de hasta 1 ventana. - Categoría 2:Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard...
Tender
Procurement Contract
Spain
Not provided on the source page. Please check the official source.
Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-15
34723
Spain – Printing paper – Sistema Dinámico de Adquisición, para la contratación del suministro de papel de distintas categorías para la S.E. Correos y Telégrafos, S.A., S.M.E. Categoría 1: Bobinas de papel blanco. Categoría 2:Papel preimpreso en bobina, prBuyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard...
Tender
Procurement Contract
Spain
Not provided on the source page. Please check the official source.
Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-17
34724
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery an...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.
34725
Bulgaria – Pharmaceutical products – Доставки на медикаментиBuyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р СТАМЕН ИЛИЕВ АД | Notice type: cn-standard | Procedure: restricted | Contrac...
Tender
Procurement Contract
Bulgaria
Not provided on the source page. Please check the official source.
